The bone scan as a tumour marker in prostatic carcinoma

G. D. Chisholm, Anthony R Stone, L. L. Beynon, M. V. Merrick

Research output: Contribution to journalArticle

5 Scopus citations


The technetium methylene diphosphate bone scan was evaluated in 100 consecutive new patients presenting with carcinoma of the prostate. 48% of the patients had a positive bone scan at the initial diagnosis. The scan was more more helpful than the skeletal X-ray in the diagnosis of bone metastases: 23% of the X-ray-negative patients were scan-positive. Serial bone scans were more sensitive than either X-rays or serum acid phosphatase in following the progress of the disease. It is concluded that the bone scan in patients with prostatic carcinoma can be used as a reliable tumour marker, especially for monitoring the course of metastases.

Original languageEnglish (US)
Pages (from-to)257-260
Number of pages4
JournalEuropean Urology
Issue number5
StatePublished - 1982
Externally publishedYes

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'The bone scan as a tumour marker in prostatic carcinoma'. Together they form a unique fingerprint.

  • Cite this

    Chisholm, G. D., Stone, A. R., Beynon, L. L., & Merrick, M. V. (1982). The bone scan as a tumour marker in prostatic carcinoma. European Urology, 8(5), 257-260.